QNCX
Quince Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website quincetx.com
- Employees(FY) 21
- ISIN US22053A1079
Performance
-1.63%
1W
-9.18%
1M
-29.3%
3M
+1.19%
6M
-13.81%
YTD
-43.08%
1Y
Profile
Quince Therapeutics, Inc., a preclinical stage biopharmaceutical company, develops precision therapeutics for debilitating and rare diseases. Its lead compound is NOV004, a systemically administered bone anabolic peptide engineered to target and concentrate at bone fracture sites. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Technical Analysis of QNCX 2024-05-10
Overview:
In analyzing the technical indicators for QNCX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide investment ...
Recent News & Updates
- 2024-05-13 01:53
- 2024-05-12 19:00
- 2024-05-06 04:05
- 2024-04-01 21:53
- 2024-03-31 19:00
- 2024-02-21 18:00
Quince Therapeutics Launches Scientific Advisory Board(Businesswire)
- 2024-02-14 18:00
- 2024-02-07 03:05
- 2024-01-04 03:05
- 2023-12-03 18:21
10 Best Debt Free Penny Stocks To Buy Now(Yahoo Finance)
- 2023-10-22 19:00
- 2023-09-28 04:05
- 2023-09-05 19:00
- 2023-08-14 22:20
Sidoti Events, LLCs Virtual August Micro-Cap Conference(Yahoo Finance)
- 2023-08-10 04:05
- 2023-07-23 19:00
- 2023-07-12 20:00
- 2023-06-05 20:00
- 2023-04-10 19:00
- 2023-04-06 04:05
- 2023-04-05 04:05
- 2023-03-21 17:00
- 2023-03-20 20:00
- 2023-01-30 03:05
- 2023-01-26 19:00
- 2022-11-20 20:09
- 2022-09-15 20:00
- 2022-09-11 20:00
- 2022-08-30 04:05
- 2022-08-25 04:05
Page 1 of 2
previousnext